Last reviewed · How we verify
durvalumab
Approved treatments
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- durvalumab patent landscape — cliff calendar, originator estates, attackable patents
- durvalumab treatment landscape brief
- durvalumab treatment updates RSS
Related
- Treatment landscape: durvalumab patent cliff · durvalumab CI report
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing